Diagnosis, a zuranolone course weighed against sertraline, driving and contraception precautions, therapy and follow-up all share one record in this final MN663 unit, built for a composite new mother. Searches like "mn 663 unit 10 assignment example", "mn663 unit 10 sample" and "mn663 unit 10 example" land here.
Comprehensive Care Plan for Postpartum Depression at Seven Weeks: Zuranolone, Sleep, Safety and Follow-Up
[Student Name]
Purdue University Global
MN663: PMHNP Diagnosis and Management Across the Lifespan I
Unit 10 Assignment
[Instructor Name]
[Date]
Composite patient written as a model document. The treatment course is bracketed as a composite; nothing here is a prescribing instruction.
Diagnosis
Major depressive disorder with peripartum onset. Symptoms began about ten days after delivery: sadness through most days, little pleasure in things she used to enjoy, poor sleep even when the baby sleeps, guilt about "not bonding" and poor concentration. Edinburgh Postnatal Depression Scale score of 19, with a score of 0 on the self-harm item (Cox et al., 1987); on direct questioning she denies thoughts of harming herself or the baby. TSH within the reference range. No history of mania or psychosis. No previous depressive episodes.
Management
Decision rule: speed of relief and her feeding choice are weighed first, then the burden of a short course against open-ended treatment.
She is formula feeding by choice and says she "cannot wait six weeks" to feel better. Two options were compared. Zuranolone, approved by the FDA in August 2023 for postpartum depression, is taken once daily in the evening for 14 days; in its phase 3 trial it improved depressive symptoms compared with placebo by day 15, with improvement seen as early as day 3 (Deligiannidis et al., 2023). Sertraline has the most experience in the postpartum period and extensive breastfeeding data, but it usually takes several weeks to work and is continued for months.
Choice: zuranolone, as a [14-day composite course], because she is not breastfeeding, wants faster relief and prefers a defined course. Sertraline remains the fallback if she does not respond or if symptoms return.
Its demands are converted into a plan. The boxed warning states that zuranolone can impair the ability to drive, and patients should not drive or operate machinery for at least 12 hours after each dose (Sage Therapeutics & Biogen, 2023). It is taken with a fat-containing evening meal. The label advises effective contraception during treatment and for one week after. For these two weeks, her partner drives in the mornings, her mother stays overnight to handle the late feeds, and she takes the dose with dinner at 7 p.m. so that by 7 a.m. the twelve-hour window has passed.
Why Not Wait or Use Therapy Alone
Therapy alone is a reasonable choice for mild to moderate postpartum depression, and it remains part of this plan. Her score of 19, her difficulty caring for herself and her strong wish for faster relief place her in the range where medication is reasonable to add now. Waiting several weeks to see whether symptoms resolve on their own was discussed and declined by her, since her symptoms have already lasted more than five weeks and are affecting her ability to enjoy her baby.
Contraception and Future Pregnancy
She and her partner use condoms and plan to discuss longer-term contraception at her postpartum visit. She was told that zuranolone's effects on a pregnancy are not well studied, which is why the label advises contraception during the course and for a week after. Her obstetric clinician is informed of the plan.
Psychotherapy
Referral to a therapist experienced in perinatal mental health for interpersonal therapy, which addresses the role transition to motherhood, starting within two weeks. She can attend by video during the first month.
Sleep and Support
Sleep loss worsens postpartum depression. Her partner and mother have agreed to cover one overnight feed each so that she gets at least one uninterrupted five-hour stretch every night, continuing beyond the zuranolone course.
Safety
A safety plan was written with her, listing her warning signs, her mother and partner as contacts, the clinic number and the 988 Suicide and Crisis Lifeline. She and her partner were told to call immediately for thoughts of harming herself or the baby, confusion, or seeing or hearing things others do not.
Education, in Her Terms
"This medicine is taken for two weeks, in the evening with dinner. It can make you very sleepy, so no driving until the next day, twelve hours later. Many people start feeling better within a few days, but it can take the full two weeks. Use birth control while you take it and for a week after. Keep going with therapy, because the medicine is short and therapy helps it last. Call us if things get worse, not only if they get better."
Coordination
The plan is shared, with her consent, with her obstetric clinician and the baby's pediatrician, who will also screen her with the Edinburgh scale at the baby's well visits. Her pharmacist is asked to check for interacting medications, since other sedating drugs and alcohol add to zuranolone's effects.
Follow-Up and Measurement
Telephone call on day 3 to ask about sedation, dizziness and mood. Visit on day 15, at the end of the course, with a repeat Edinburgh score. Visits at weeks 4, 8 and 12 after the course, because relapse monitoring is where plans built on a short treatment most often go quiet. If her Edinburgh score is 13 or higher at any follow-up, or symptoms return, sertraline is started and therapy is intensified.
References
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression: Development of the 10-item Edinburgh Postnatal Depression Scale. British Journal of Psychiatry, 150(6), 782-786. https://doi.org/10.1192/bjp.150.6.782
Deligiannidis, K. M., Meltzer-Brody, S., Maximos, B., Peeper, E. Q., Freeman, M., Lasser, R., Bullock, A., Kotecha, M., Li, S., Forrestal, F., Rana, N., Garcia, M., Leclair, B., & Doherty, J. (2023). Zuranolone for the treatment of postpartum depression. American Journal of Psychiatry, 180(9), 668-675. https://doi.org/10.1176/appi.ajp.20220785
Sage Therapeutics & Biogen. (2023). Zurzuvae (zuranolone) capsules: Prescribing information. Biogen.
How this MN663 Unit 10 example is structured
Each section of the record depends on the one before it. Diagnosis is kept short because it is settled, but it carries the details later sections need: onset timing, severity, the self-harm item and the thyroid result. Management then states its decision rule, speed of relief weighed against breastfeeding data and a two-week course weighed against open-ended treatment, before comparing the two agents. The chosen course is bracketed as a composite, and its practical demands, evening dosing with a fat-containing meal and no driving afterward, are converted into a plan for who drives and who handles night feeds during those two weeks. Education restates the plan in her terms without introducing anything new. Follow-up names what happens after the course ends, since relapse monitoring is where plans built on a short treatment most often go quiet.
Get an MN663 Unit 10 example written to your instructions
Gather what Unit 10 supplies, the case and any MN663 plans from earlier units it should build on, plus the rubric. A first care plan is free and returns within 24-48h as a single record: diagnosis, a reasoned choice between treatments, safety, education in plain terms and dated follow-up, each section written to depend on the last. The paper above is an original model document written by our desk, not a submitted student paper and not an official Purdue University Global document.
MN663 Unit 10 questions, answered
How is a comprehensive care plan different from a management plan?
Scope and integration. A management plan centers on the intervention, its reasoning and its monitoring. A comprehensive care plan adds diagnosis, education, safety, family involvement and coordination, and it is judged on whether those parts fit together. Expect graders to read it as a single record another clinician would inherit, so internal consistency matters as much as any one section.
Should the plan use a newly approved drug if the case allows it?
Only if the argument supports it for this person. A new approval widens the options but does not make the new drug the default. Compare it with an established alternative on the factors the case supplies, such as feeding method, speed and safety requirements, and cite the label and trial evidence accurately, including approval dates.
What does the plan owe the self-harm item on a screening scale?
Report the item score explicitly, whatever it is, and show the response. A positive answer requires a documented safety assessment and plan; a zero still deserves a sentence noting it was reviewed and when it will be asked again. Leaving the item unmentioned is one of the most serious omissions a mental health care plan can contain.